GlassScriptPhysician profile
Dantwan Shawntel Smith
NPI 1659866895
$9,726.99
in general payments reported to CMS, 2019-2025
31 companies · $4,215 in 2025
The $4,215 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.32 · 2020: $290 · 2021: $1,230 · 2022: $1,031 · 2023: $1,241 · 2024: $1,704 · 2025: $4,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,581 · Travel and Lodging: $2,316 · Education: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,581.11 |
| Travel and Lodging | $2,315.82 |
| Education | $262.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,799.56 | 2022-2025 | Corevalve Evolut R, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $1,738.13 | 2021-2025 | Watchman Access System |
| Abbott Laboratories | $936.52 | 2021-2025 | Ensite, Xience Skypoint, Mitraclip |
| Edwards Lifesciences Corporation | $833.87 | 2024-2025 | Sapien 3 Ultra Resilia, Pascal |
| Boehringer Ingelheim Pharmaceuticals, INC. | $533.80 | 2021-2023 | Jardiance |
| Inari Medical, INC. | $518.56 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $510.39 | 2022-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $414.66 | 2020-2023 | Brilinta |
| Novartis Pharmaceuticals Corporation | $326.17 | 2021-2025 | |
| Penumbra, INC. | $308.22 | 2023-2024 | Indigo System |
| Shockwave Medical, INC | $299.89 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $257.40 | 2020-2023 | |
| Irhythm Technologies, INC. | $224.24 | 2022-2023 | Zio Xt Patch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $177.52 | 2021-2025 | Lifevest |
| Cvrx, INC. | $145.57 | 2024 | Barostim Neo System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $127.68 | 2021-2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $118.40 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $100.28 | 2019-2022 | |
| Chiesi USA, INC. | $70.29 | 2024 | Kengreal |
| Livanova USA, INC. | $42.68 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.26 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $32.79 | 2023 | Uptravi |
| Amgen INC. | $29.23 | 2020-2022 | |
| Teleflex LLC | $22.82 | 2025 | Guideliner |
| Impulse Dynamics (USA) INC. | $21.14 | 2023 | Optimizer |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.01 | 2021 | |
| La Jolla Pharmaceutical Company | $19.76 | 2021 | |
| Akcea Therapeutics, INC. | $18.94 | 2020 | |
| Scpharmaceuticals INC. | $16.96 | 2024 | |
| Vifor Pharma, INC. | $14.63 | 2021 | |
| Abbvie INC. | $11.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dantwan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.